Skip to main content

Advertisement

SpringerLink
Log in

A case of systemic lupus erythematosus expressing intractable thrombocytopenia remedied effectively by intermittent and continuous administrations of a small amount of immune globulin

  • CASE REPORT
  • Published:
Modern Rheumatology

Abstract

We describe a case where intermittent and continuous administrations of a small amount of immune globulin were effective in the treatment of refractory chronic immune thrombocytopenic purpura by systemic lupus erythematosus (SLE). Steroid pulse therapy and cyclophosphamide pulse therapy were considered for thrombopenia. However, the patient had compressed fracture of the lumbar vertebrae due to osteoporosis and right external malleolus ulcer with complications of infection. Therefore, high-dose intravenous immune globulin (IVIG) therapy (400 mg/kg daily for 5 consecutive days) was administered. Then, as a maintenance therapy, a small amount of 400 mg/kg for 1 day (400 mg/kg monthly) was given in an intermittent and continuous manner, which resulted in improvement of thrombocytopenia and reduction of the amount of steroid administered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C Arnal JC Piette J Leon B Taillan E Hachulla F Roudot-Thoraval (2002) ArticleTitleTreatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases J Rheumatol 29 75–83 Occurrence Handle11824975 Occurrence Handle1:CAS:528:DC%2BD38XnsFWisg%3D%3D

    PubMed  CAS  Google Scholar 

  2. EM Tan AS Cohen JI Fries AT Masi DJ Mcshane NF Rothfield (1982) ArticleTitleThe 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1271–7 Occurrence Handle10.1002/art.1780251101 Occurrence Handle7138600 Occurrence Handle1:STN:280:DyaL3s%2FkvVCmtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  3. C Bombardier DD Gladman MB Urowitz D Caron CH Chang (1992) ArticleTitleDerivation of the SLEDAI Arthritis Rheum 35 630–40 Occurrence Handle10.1002/art.1780350606 Occurrence Handle1599520 Occurrence Handle1:STN:280:DyaK383oslWrtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  4. P Imbach S Barandim C Baumgartner A Hirt F Hofer HP Wagner (1981) ArticleTitleHigh-dose intravenous gammaglobulin therapy of refractory in particular idiopathic thrombocytopenia in childhood Helv Pediatr Acta 46 81–6

    Google Scholar 

  5. P Imbach S Barandum V d'Apuzzo C Baumgartner A Hirt A Morell et al. (1981) ArticleTitleHigh-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood Lancet 2 1228–31 10.1016/S0140-6736(81)92400-4 Occurrence Handle10.1016/S0140-6736(81)92400-4

    Article  Google Scholar 

  6. RE Schmidt U Budde G Schafer I Stroehumann (1981) ArticleTitleHigh-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura Lancet 1 475–6 10.1016/S0140-6736(81)90810-2 Occurrence Handle10.1016/S0140-6736(81)90810-2

    Article  Google Scholar 

  7. K Yasunaga H Uchino J Akatsuka (1985) ArticleTitleAssessment of high-dose immunoglobulin therapy in patients with advanced idiopathic thrombocytopenic purpura Naika Hokan 32 121–39

    Google Scholar 

  8. M Terai ST Shulman (1997) ArticleTitlePrevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globurin dose but independent of salicylate dose J Pediatr 131 888–93 10.1016/S0022-3476(97)70038-6 Occurrence Handle10.1016/S0022-3476(97)70038-6 Occurrence Handle9427895 Occurrence Handle1:STN:280:DyaK1c%2FovFeltg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  9. M Mori T Miyamae T Imagawa S Katakura K Kimura S Yokota (2004) ArticleTitleMeta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease Mod Rheumatol 14 361–6 10.1007/s10165-004-0324-3 Occurrence Handle10.1007/s10165-004-0324-3 Occurrence Handle17143694 Occurrence Handle1:CAS:528:DC%2BD2cXpt1ehs74%3D

    Article  PubMed  CAS  Google Scholar 

  10. MC Dalakas I Illa JM Dambrosia SA Soueidan DP Stein C Otero et al. (2000) ArticleTitleA control trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis N Engl J Med 329 1993–2000 10.1056/NEJM199312303292704 Occurrence Handle10.1056/NEJM199312303292704

    Article  Google Scholar 

  11. S Genevay A Saudan-Kister P-A Guerne (2001) ArticleTitleIntravenous gammaglobulins in refractory polymyositis: lower dose for maintenance treatment is effective Ann Rheum Dis 60 635–6 10.1136/ard.60.6.635 Occurrence Handle10.1136/ard.60.6.635 Occurrence Handle11350855 Occurrence Handle1:STN:280:DC%2BD3M3lt1ajsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  12. P Cherin S Pelletier A Teixeira (2002) ArticleTitleResults and long-term follow-up of intravenous immunoglobulin infusion in chronic refractory polymyositis Arthritis Rheum 46 467–74 10.1002/art.10053 Occurrence Handle10.1002/art.10053 Occurrence Handle11840450 Occurrence Handle1:CAS:528:DC%2BD38XhvF2qsr0%3D

    Article  PubMed  CAS  Google Scholar 

  13. C Franconi M Galeazzi A Fioravanti R Gelli F Megale R Marcolongo (1994) ArticleTitleLong term I.V. Ig treatment in systemic lupus erythematosus Clin Exp Rheumatol 12 163–8

    Google Scholar 

  14. CA Heyneman CA Gudger JV Beckwith (1997) ArticleTitleIntravenous immune globulin for inducing remissions in systemic lupus erythematosus Ann Pharmacother 31 242–4 Occurrence Handle9034428 Occurrence Handle1:CAS:528:DyaK2sXhsVKhtrY%3D

    PubMed  CAS  Google Scholar 

  15. Y Levy Y Sherer A Ahmed P Langevitz J George F Fabbrizzi et al. (1999) ArticleTitleA study of 20 SLE patients with intravenous immunoglobulin — clinical and serologic response Lupus 8 705–12 10.1191/096120399678841007 Occurrence Handle10.1191/096120399678841007 Occurrence Handle10602441 Occurrence Handle1:STN:280:DC%2BD3c%2FntVegug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  16. S Kamali A Cefle M Sayarlioglu A Gul M Inanc L Ocal et al. (2005) ArticleTitleExperience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases Rheumatol Int 25 211–4 10.1007/s00296-003-0422-0 Occurrence Handle10.1007/s00296-003-0422-0 Occurrence Handle14722731 Occurrence Handle1:CAS:528:DC%2BD2MXjtFehtbk%3D

    Article  PubMed  CAS  Google Scholar 

  17. JO Schroeder RA Zeuner HH Euler H Loffler (1996) ArticleTitleHigh dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study J Rheumatol 23 71–5 Occurrence Handle8838511 Occurrence Handle1:STN:280:DyaK28vjsFKhtw%3D%3D

    PubMed  CAS  Google Scholar 

  18. JN Boletis JPA Loannidis KA Boki HM Moutsopoulos (1999) ArticleTitleIntravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis Lancet 354 569–70 10.1016/S0140-6736(99)01575-5 Occurrence Handle10.1016/S0140-6736(99)01575-5 Occurrence Handle10470708 Occurrence Handle1:CAS:528:DyaK1MXlvVKgs7g%3D

    Article  PubMed  CAS  Google Scholar 

  19. M Goodfield K Davison K Bowden (2004) ArticleTitleIntravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus J Dermatol Treat 15 46–50 10.1080/09546630310017843 Occurrence Handle10.1080/09546630310018789 Occurrence Handle1:CAS:528:DC%2BD2cXisFKhtrg%3D

    Article  CAS  Google Scholar 

  20. M Ballow (1996) Mechanisms of action of intravenous immunoglobulin: clinical implications in autoimmune and inflammatory diseases MD Kazatchkine A Morell (Eds) Intravenous immunoglobulin research and therapy Parthenon New York 123–8

    Google Scholar 

  21. A Samuelsson TL Towers JV Ravetch (2001) ArticleTitleAnti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor Science 291 484–6 10.1126/science.291.5503.484 Occurrence Handle10.1126/science.291.5503.484 Occurrence Handle11161202 Occurrence Handle1:CAS:528:DC%2BD3MXlslensw%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Health and Sport Management, Osaka University of Health and Sport Sciences, 1-1 Asashirodai, Kumatoricho, Sennan, Osaka, 590-0496, Japan

    Etsuko Maeshima

  2. Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan

    Etsuko Maeshima, Yohei Kida, Mikako Goda & Yoshinobu Minami

Authors
  1. Etsuko Maeshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yohei Kida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mikako Goda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshinobu Minami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Etsuko Maeshima.

About this article

Cite this article

Maeshima, E., Kida, Y., Goda, M. et al. A case of systemic lupus erythematosus expressing intractable thrombocytopenia remedied effectively by intermittent and continuous administrations of a small amount of immune globulin. Mod Rheumatol 16, 239–242 (2006). https://doi.org/10.1007/s10165-006-0482-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-006-0482-6

Key words

Search

Navigation